ClinicalTrials.Veeva

Menu

Leucine Supplementation and Skeletal Muscle Disuse

U

University of Sao Paulo

Status

Completed

Conditions

Disuse Atrophy

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Leucine

Study type

Interventional

Funder types

Other

Identifiers

NCT01192009
2009/02896-6

Details and patient eligibility

About

Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.

Enrollment

22 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of anterior cruciate ligament injury
  • Physically active
  • Must be able to swallow tablets
  • Non-smokers
  • Do not use nutritional supplements

Exclusion criteria

  • Post-surgical complications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

22 participants in 2 patient groups, including a placebo group

Immobilization and Leucine
Experimental group
Treatment:
Dietary Supplement: Leucine
Immobilization and Placebo
Placebo Comparator group
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems